ABBY PICARD: Open Payments
NPI 1730549197 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 17 payments from 13 companies in 2025. Trend: 2023 $598 · 2024 $444 · 2025 $486
Food & beverage: $387Education: $99
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Galderma Laboratories, L.P. | 3 | $56 |
| ABBVIE INC. | 2 | $53 |
| Arcutis Biotherapeutics, Inc. | 2 | $40 |
| Sandoz Inc. | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Incyte Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| LEO Pharma Inc. | 1 | $26 |
| GENZYME CORPORATION | 1 | $25 |
Products named: DUPIXENT, Zoryve, NEMLUVIO, HYRIMOZ, SKYRIZI, OPZELURA, EBGLYSS, ADBRY.
Industry payments across MA — which companies pay providers there.
